Clinical Trial Update: Tracking Peripheral Immune Cell Infiltration of the Brain in Central Inflammatory Disorders Using [Zr-89]Oxinate-4-labeled Leukocytes. [Phase 1]

View source ↗

Summary

Phase 1 clinical trial using zirconium-89 labeled leukocytes to visualize brain immune cell infiltration in central inflammatory disorders; the study involving …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatigue Syndrome
• Fibromyalgia
• Multiple Sclerosis

Drugs mentioned

• [Zr-89]Oxinate-4-labeled Leukocytes

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Fibromyalgia, Chronic Fatigue Syndrome | Phase 1 | Status: SUSPENDED